Where does Q-linea AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Q-linea AB ranks #10,435 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Q-linea AB hold?

Q-linea AB holds 30 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Q-linea AB's Innovation Score?

Q-linea AB has an Innovation Score of 45.4 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Q-linea AB's patent grant rate increasing or decreasing?

Q-linea AB's recent grant velocity is +375% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Q-linea AB's patents?

Q-linea AB's patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Q-linea AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Q-linea AB

Q: What technology areas does Q-linea AB focus on?

Q-linea AB's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 13 patents, ranking #353 of 2,502 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 30 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Q-linea ranks #10,435 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 13 technology areas.

#10,435
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.4/100): 14.0
avg claims per patent: +375%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10435 · Foreign Corporation #10,435 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,435/49,997
PHOTO-FINISH Precigen
CPC-FOCUS C12Q · 13 areas
INNOV-PAR 45.4/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +375% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Precigen, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Q-linea’s 45.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (26%) Velocity 12.4 pts (27%) Breadth 12.7 pts (28%) Claim depth 8.4 pts (19%)

Qualcomm Incorporated · highest

85
Alstom Renewable · near

45
Nippon Filcon · near

45
Position Imaging · near

45
Powercast · near

45
Q-linea AB · this assignee

45
3D Lighting… · lowest

7

What this shows Q-linea's Innovation Score is 45.4/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Q-linea?

Each dot is one of Q-linea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Q-linea’s own 14.0 claims/patent is at or below the 14.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Q-linea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Q-linea's grants concentrate

Q-linea AB is a focused PatentsView assignee: 13 CPC subclasses with 43.3% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2015. By volume, Q-linea sits between Precigen, Inc. and Rtic Outdoors, LLC.

Q-linea's three-year grant acceleration

Q-linea AB shows 13 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Precigen

30
Premier Marine

30
Printed Energy Pty

30
Proto Labs

30
Qwtip

30
RCM Enterprise L…

30
Recensmedical

30
Rtic Outdoors

30
Q-linea AB ◀

30

What this shows Q-linea holds 30 patents at rank #10,435, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Q-linea

By rank, the assignees closest to #10,435 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Q-linea's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Q-linea, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Q-linea ranks #353 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Powercast Corporation 45 Nippon Filcon Co., Ltd. 45 Position Imaging, Inc. 45 Alstom Renewable Technologies 45

Q-linea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Q-linea AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.3%
2017	1	3.3%
2018	1	3.3%
2019	1	3.3%
2020	4	13.3%
2021	2	6.7%
2022	6	20.0%
2023	3	10.0%
2024	4	13.3%
2025partial year	7	23.3%

Which technologies does Q-linea AB patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 13

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 9

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 8

G02B - Optical Elements, Systems OR Apparatus 7

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

G06T - Image Data Processing OR Generation, IN General 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G06V - Image OR Video Recognition OR Understanding 1

H04N - Pictorial Communication, e.g. Television 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Q-linea AB's patent record in context - here's where to go next.

Q-linea AB's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 43.3% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #10,435 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Q-linea AB against Precigen, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.